Accounting for pharmacokinetic differences in dual-tracer receptor density imaging

Physics in Medicine and Biology

Volumn 59, Issue 10, 2014, Pages 2341-2351

  Tichauer, K M ^a   Diop, M ^b   Elliott, J T ^c   Samkoe, K S ^c   Hasan, T ^d   Lawrence, K S ^b   Pogue, B W ^c,d  

^a Illinois Institute of Technology   (United States)

^b UNIVERSITY OF WESTERN ONTARIO   (Canada)

^c DARTMOUTH COLLEGE   (United States)

^d MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

affibodies; cancer; epidermal growth factor receptor; fluorescence imaging; tracer kinetics; xenograft mouse model

Indexed keywords

BLOOD; CELL MEMBRANES; CYTOLOGY; DECONVOLUTION; DISEASES; MAMMALS; MOLECULAR IMAGING; TUMORS;

AFFIBODIES; CANCER; EPIDERMAL GROWTH FACTOR RECEPTORS; FLUORESCENCE IMAGING; MOUSE MODELS; TRACER KINETICS;

PHARMACOKINETICS;

EGFR PROTEIN, HUMAN; EPIDERMAL GROWTH FACTOR RECEPTOR; TRACER;

ANIMAL; CAROTID ARTERY; CELL TRANSFORMATION; FEMALE; HUMAN; KINETICS; METABOLISM; MOLECULAR IMAGING; MOUSE; PROCEDURES; TISSUE DISTRIBUTION; TUMOR CELL LINE;

ANIMALS; CAROTID ARTERIES; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; KINETICS; MICE; MOLECULAR IMAGING; RADIOACTIVE TRACERS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE DISTRIBUTION;

EID: 84899556902     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/59/10/2341     Document Type: Article

References (24)

1. Choi H S et al 2013 Targeted zwitterionic near-infrared fluorophores for improved optical imaging Nature Biotechnol. 31 148-53
2. de Lussanet Q G, Langereis S, Beets-Tan R G, van Genderen M H, Griffioen A W, van Engelshoven J M and Backes W H 2005 Dynamic contrast-enhanced MR imaging kinetic parameters and molecular weight of dendritic contrast agents in tumor angiogenesis in mice Radiology 235 65-72 (Pubitemid 40432238)
3. Diop M and St. Lawrence K 2012 Deconvolution method for recovering the photon time-of-flight distribution from time-resolved measurements Opt. Lett. 37 2358-60
4. Elliott J T, Tichauer K M, Samkoe K S, Gunn J R, Sexton K J and Pogue B W 2014 Direct characterization of arterial input functions by fluorescence imaging of exposed carotid artery to facilitate kinetic analysis Mol. Imaging Biol. at press (PMID: 24420443)
5. Friedman M, Nordberg E, Hoiden-Guthenberg I, Brismar H, Adams G P, Nilsson F Y, Carlsson J and Stahl S 2007 Phage display selection of Affibody molecules with specific binding to the extracellular domain of the epidermal growth factor receptor Protein Eng. Des. Sel. 20 189-99 (Pubitemid 351321300)
6. Gao X, Cui Y, Levenson R M, Chung L W and Nie S 2004 In vivo cancer targeting and imaging with semiconductor quantum dots Nature Biotechnol. 22 969-76 (Pubitemid 39014473)
7. Gibaldi M and Koup J R 1981 Pharmacokinetic concepts - drug binding, apparent volume of distribution and clearance Eur. J. Clin. Pharmacol. 20 299-305 (Pubitemid 11052671)
8. Gunn R N, Lammertsma A A, Hume S P and Cunningham V J 1997 Parametric imaging of ligand-receptor binding in PET using a simplified reference region model NeuroImage 6 279-87 (Pubitemid 28018717)
9. Innis R B et al 2007 Consensus nomenclature for in vivo imaging of reversibly binding radioligands J. Cereb. Blood Flow Metab. 27 1533-9 (Pubitemid 47301451)
10. Kety S S 1951 The theory and applications of the exchange of inert gas at the lungs and tissues Pharmacol. Rev. 3 1-41
11. Lammertsma A A, Bench C J, Hume S P, Osman S, Gunn K, Brooks D J and Frackowiak R S 1996 Comparison of methods for analysis of clinical [11C]raclopride studies J. Cereb. Blood Flow Metab. 16 42-52
12. Lammertsma A A and Hume S P 1996 Simplified reference tissue model for PET receptor studies NeuroImage 4 153-8 (Pubitemid 27024284)
13. Liu J T, Helms M W, Mandella M J, Crawford J M, Kino G S and Contag C H 2009 Quantifying cell-surface biomarker expression in thick tissues with ratiometric three-dimensional microscopy Biophys. J. 96 2405-14
14. Logan J, Fowler J S, Volkow N D, Wang G J, Ding Y S and Alexoff D L 1996 Distribution volume ratios without blood sampling from graphical analysis of PET data J. Cereb. Blood Flow Metab. 16 834-40 (Pubitemid 26292051)
15. Mintun M A, Raichle M E, Kilbourn M R, Wooten G F and Welch M J 1984 A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography Ann. Neurol. 15 217-27 (Pubitemid 14164735)
16. Nicholson R I, Gee J M and Harper M E 2001 EGFR and cancer prognosis Eur. J. Cancer 37 S9-15
17. Olafsen T and Wu A M 2010 Antibody vectors for imaging Semin. Nucl. Med. 40 167-81
18. Pogue B W, Samkoe K S, Hextrum S, O'Hara J A, Jermyn M, Srinivasan S and Hasan T 2010 Imaging targeted-agent binding in vivo with two probes J. Biomed. Opt. 15 030513
19. Tichauer K M, Deharvengt S J, Samkoe K S, Gunn J R, Bosenberg M W, Turk M J, Hasan T, Stan R V and Pogue B W 2013 Tumor endothelial marker imaging in melanomas using dual-tracer fluorescence molecular imaging Mol. Imaging Biol. (PMID: 24217944)
20. Tichauer K M, Samkoe K S, Klubben W S, Hasan T and Pogue B W 2012a Advantages of a dual-tracer model over reference tissue models for binding potential measurement in tumors Phys. Med. Biol. 57 6647-59
21. Tichauer K M, Samkoe K S, Sexton K J, Hextrum S K, Yang H H, Klubben W S, Gunn J R, Hasan T and Pogue B W 2012b In vivo quantification of tumor receptor binding potential with dual-reporter molecular imaging Mol. Imaging Biol. 14 584-92
22. Wang D, Chen Y, Leigh S Y, Haeberle H, Contag C H and Liu J T 2012 Microscopic delineation of medulloblastoma margins in a transgenic mouse model using a topically applied VEGFR-1 probe Trans. Oncol. 5 408-14
23. Yaehne K et al 2013 Nanoparticle accumulation in angiogenic tissues: towards predictable pharmacokinetics Small 9 3118-27
24. Yuan F, Dellian M, Fukumura D, Leunig M, Berk D A, Torchilin V P and Jain R K 1995 Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size Cancer Res. 55 3752-6